Richard Hobbs is a Pro-Vice-Chancellor (without portfolio) at the University of Oxford, where he holds the inaugural PCRT Mercian Chair in Primary Care (2022-)
Previously the inaugural Nuffield Professor of Primary Care (2011-22) at the Nuffield Department of Primary Care Health Sciences (2011-2024), he remains Director of the Oxford Institute of Digital Health (2020-) and is Lead for Global Partnerships for Oxford Primary Care. He delivered 42 years of service to the NHS as a doctor, 38 years committed to a disadvantaged and challenging inner-city practice until 2019, and 34 years of leadership and excellence as a clinical scientist focussed mainly upon primary care, clinical epidemiology, and vascular disease.
He is one of the world’s foremost primary care academics and has held many national and international leadership roles, leading the development of two of Europe’s most highly rated centres for academic primary care, firstly at Birmingham and since 2011 at Oxford, now one of the largest and most successful centres for academic primary care in the world. He has made major contributions to growing primary care academic capacity, in terms of people development and research networks. He was the fifth recipient of the RCGP Discovery Prize in 2018 (occasional awards since 1953) and was awarded a CBE for services to medical research in 2018 in the Queen’s New Year’s Honours List. He has an outstanding track record in cardiovascular disease research, delivering trials that changed international guidelines and practice, especially in the areas of stroke prevention in atrial fibrillation (BAFTA, SAFE, and SMART trials), heart failure burden and diagnosis (ECHOES and REFER trials), and hypertension self-management (TASMINH 1-5).
He made many non-remunerated contributions to educational charitable boards, serving as trustee on some 7 learned societies and universities. Within universities, he has led several major change initiatives and the associated people management within Oxford University. He also leads a new Institute of Applied Digital Science at Oxford.
At the onset of COVID-19 he re-tasked much of his research to urgent COVID studies and is co-Chief Investigator of all the UK National Urgent Public Health Priority Studies in primary care, namely the national repurposed therapies platform trial (PRINCIPLE), national COVID Surveillance (Oxford-RCGP RSC), the national PC diagnostics platform trial (RAPTOR/CONDOR), and the national COVID novel anti-viral platform trial (PANORAMIC). Several papers during Covid ranked top 10 in the world for downloads by SSRN, who also list him as a ‘highly cited global researcher’.
He has authored over 600 peer reviewed publications, has an h-index of 121, i10-index of 498, with >140,000 citations (>60,000 since 2019), with 136 papers with >100 citations, 20 papers >1000, and 15 papers >2000.
